Last reviewed · How we verify
Commercialized IPV
At a glance
| Generic name | Commercialized IPV |
|---|---|
| Sponsor | Jiangsu Province Centers for Disease Control and Prevention |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (PHASE1)
- A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy Infants (PHASE2, PHASE3)
- Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine. (PHASE2)
- Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Commercialized IPV CI brief — competitive landscape report
- Commercialized IPV updates RSS · CI watch RSS
- Jiangsu Province Centers for Disease Control and Prevention portfolio CI